Squarepoint
ARKG icon

Squarepoint’s ARK Genomic Revolution ETF ARKG Stock Holding History

Squarepoint’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,500
Closed -$246K – 4244
2025
Q4 		$246K Sell
8,500
-25,900
-75% -$777K ﹤0.01% 3739
2025
Q3 		$955K Sell
34,400
-22,400
-39% -$566K ﹤0.01% 2726
2025
Q2 		$1.38M Buy
56,800
+22,200
+64% +$486K ﹤0.01% 2374
2025
Q1 		$718K Sell
34,600
-65,900
-66% -$1.66M ﹤0.01% 2952
2024
Q4 		$2.37M Buy
+100,500
New +$2.47M ﹤0.01% 2272
2021
Q3 		– Sell
-7,500
Closed -$694K – 2883
2021
Q2 		$694K Sell
7,500
-300
-4% -$25.5K ﹤0.01% 1902
2021
Q1 		$692K Buy
+7,800
New +$774K ﹤0.01% 1788

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Squarepoint's ARKG Position: Q3 2025 in Review

Squarepoint sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 49,842 shares — an estimated $1.26M sold.

Squarepoint first reported a position in ARKG in Q4 2024 and held it in 3 quarters. The position peaked at $1.42M in Q1 2025. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Squarepoint reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 49,842 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $1.26M.
  • Squarepoint first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 3 quarters.
  • Squarepoint's ARK Genomic Revolution ETF position peaked at $1.42M in Q1 2025.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.